scholarly journals Herpes Zoster: Clinical Manifestation, Treatment, and Prevention

2020 ◽  
Vol 4 (3) ◽  
pp. 34-44
Author(s):  
Muhammad Izazi Hari Purwoko ◽  
Hari Darmawan

Herpes zoster (HZ, shingles, zoster) is a disease due to reactivation and multiplication of persistent varicella zoster virus (VVZ) after suffering from previous varicella with characteristics of dermatomal rashes, pain, and unilateral. Dermatoms most often involved in HZ lesions are thoracal, trigeminal, lumbal, and cervical. The first lesion is usually erythematous macule or papule, which then turns into vesicle, then to pustule and to become crust, and persists for 2-3 weeks. The main goal of antiviral therapy in HZ patients is to reduce the expansion, duration, and severity of rashes and pain in primary dermatomes; prevent the spread of HZ to other places; and prevent post-herpes neuralgia. One of the prevention strategies for HZ in the elderly and high-risk individuals is vaccination using the varicella zoster virus vaccine that is live zoster vaccine or recombinant zoster vaccine.

2020 ◽  
Vol 8 (F) ◽  
pp. 203-207
Author(s):  
Vina Yuwanda

Herpes zoster ophthalmicus (HZO) is a reactivation of HZ virus that is latent in ophthalmic division of trigeminal ganglion. Patients over 50 years old, premature infant, pregnancy woman, receiving immunosuppressive agents, and malignancies are at risk of having HZO. Ocular manifestations of HZ are ectropion, entropion, ectopic eyelash, keratitis, conjunctivitis, symblepharon, hypoesthesia, episcleritis, scleritis, scleral atrophy and thinning, uveitis, iris atrophy, posterior synechiae, acute retinal necrosis, progressive outer retinal necrosis, retinal detachment, retina atrophy, optic neuritis, optic atrophy, and strabismus. Polymerase chain reaction, antigen detection, and antibody detection can help to confirm diagnosis. Pharmacology treatments for HZ ophthalmicus are antiviral drugs, corticosteroids, analgesics, tricyclic antidepressants, and antiepileptic drug. Non-pharmacology therapies are scleral contact lens, phototherapeutic keratectomy, photorefractive keratectomy, and penetrating keratoplasty. There are two kinds of vaccination which can be given to patients: Live-attenuated varicella zoster vaccine and recombinant zoster vaccine. It is recommended by Centers for Disease Control and Prevention and Food and Drugs Administration to use recombinant zoster vaccine by 50 years old.


2009 ◽  
Vol 200 (7) ◽  
pp. 1068-1077 ◽  
Author(s):  
Adriana Weinberg ◽  
Jane H. Zhang ◽  
Michael N. Oxman ◽  
Gary R. Johnson ◽  
Anthony R. Hayward ◽  
...  

2018 ◽  
Vol 217 (7) ◽  
pp. 1055-1059 ◽  
Author(s):  
Myron J Levin ◽  
Guang-Yun Cai ◽  
Katherine S Lee ◽  
Nadine G Rouphael ◽  
Aneesh K Mehta ◽  
...  

2014 ◽  
Vol 58 (8) ◽  
pp. 1125-1128 ◽  
Author(s):  
H. F. Tseng ◽  
D. S. Schmid ◽  
R. Harpaz ◽  
P. LaRussa ◽  
N. J. Jensen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document